Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
2894 participants
INTERVENTIONAL
2024-05-28
2030-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
NCT06276647
Improving Women's Health Through Coordinated Postpartum Planning
NCT05430815
Monitoring and Outreach for Maternal Safety Postpartum
NCT06899737
Helping Moms to be Healthy After Baby
NCT03257657
Care After Pregnancy Study (CAPS): Engaging Women in Postpartum Care
NCT04257552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
AIM (AIM Alliance for Innovation on Maternal Health) safety bundles delivered in-person
No interventions assigned to this group
Usual Care plus H.E.A.R. for Mamas
H.E.A.R. for Mamas is designed to provide the AIM (Alliance for Innovation on Maternal Health) Postpartum Discharge Transition education systematically and to frequently monitor women for signs and symptoms of postpartum complications using simple, patient-centered technology (text/phone).
H.E.A.R. for Mamas
H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
H.E.A.R. for Mamas
H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 16-49 years old.
* Insured by Medicaid.
\- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit.
Exclusion Criteria
* Plans to discontinue Medicaid health insurance during the postpartum year.
* Speaks a language other than English or Spanish.
* Incarcerated/pending incarceration during peripartum period.
* Currently institutionalized.
* Enrolled in current MUSC study funded by PCORI (#Pro00123833)
* Does not have and/or does not wish to use their personal cell phone for the study.
* Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from.
* Unable or unwilling to commit to completing surveys or an interview.
* Speaking a language other than English.
16 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Constance Guille
Professor - Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Constance Guille, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00130902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.